Sektkellerei Schloss Wachenheim AG (SWA) | Finanzwire

Basculer en Français

8296	Companies
114899	Keywords
55320	Articles
62454	Press releases

Headlines Articles Press releases Sektkellerei Schloss Wachenheim AG

Home
Companies
Sektkellerei Schloss Wachenheim AG

BRIEF

published on 11/11/2024 at 15:36, 9 days 21 hours ago

Schloss Wachenheim AG: First Berlin Reiterates Buy Rating

First Berlin Equity Research Sales Projections Schloss Wachenheim AG Consumer Confidence Q1 24/25 Performance
PRESS RELEASE

published on 11/11/2024 at 15:31, 9 days 21 hours ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reiterates Buy rating and €22 price target for Schloss Wachenheim AG based on Q1 24/25 results

First Berlin Equity Research BUY Rating Schloss Wachenheim AG Q1 24/25 Results €22 Price Target
BRIEF

published on 09/30/2024 at 15:12, 1 month 20 days ago

First Berlin Equity Research Reiterates Buy on Schloss Wachenheim AG

Financial Results Buy Recommendation Schloss Wachenheim AG EBIT Growth Inflation Impact
PRESS RELEASE

published on 09/30/2024 at 15:07, 1 month 20 days ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating on Schloss Wachenheim AG with EUR 22.00 target price. 2023/24 results show 3.7% sales growth and 3.0% rise in EBIT. Management expects 2024/25 improvements driven by France segment

First Berlin Equity Research Sales Growth Schloss Wachenheim AG EBIT Rise EUR 22.00 Target Price
BRIEF

published on 05/13/2024 at 11:46, 6 months 8 days ago

Schloss Wachenheim AG Maintains Positive Outlook Despite Mixed Q3 Results

Financial Results Investment Recommendation Schloss Wachenheim AG Equity Research Restructuring Costs
PRESS RELEASE

published on 05/13/2024 at 11:41, 6 months 8 days ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms BUY recommendation for Schloss Wachenheim AG with a target price of €22.00. Q3 23/24 results show sales growth and EBIT impact from restructuring costs

First Berlin Equity Research Schloss Wachenheim AG Restructuring Costs Q3 23/24 Results EUR 22.00
BRIEF

published on 02/26/2024 at 14:06, 8 months 23 days ago

First Berlin confirms its purchase recommendation on Schloss Wachenheim

Financial Results First Berlin Equity Research Inflation Purchase Recommendation Schloss Wachenheim
PRESS RELEASE

published on 02/26/2024 at 14:06, 8 months 23 days ago

Original-Research: Schloss Wachenheim (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Schloss Wachenheim AG with a target price of €22.00 following Q2 23/24 results. Despite challenges, SWA maintains sales growth outlook at 5% for the full year

First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q2 23/24 Results €22.00 Target Price
PRESS RELEASE

published on 09/26/2023 at 10:26, 1 year 1 month ago

Original-Research: Schloss Wacheneheim AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/11/2023 at 11:21, 1 year 6 months ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 11/21/2024 at 13:00, 25 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 25 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 25 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 25 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 25 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 10 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 50 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 10 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 18 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 25 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 27 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 5 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 40 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 40 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE